Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




3D Radiation Therapy Increases Lung Cancer Survival

By HospiMedica staff writers
Posted on 11 Sep 2006
Sophisticated three-dimensional (3D) radiation therapy has been shown to be more effective at curing lung cancer than older two-dimensional (2D) radiation therapy for some patients with early stage lung cancer, according to a new study.

Non-small cell lung cancer (NSCLC) accounts for 87% of all lung cancers diagnosed. More...
At present, the best treatment for stage I NSCLC is surgery or stereotactic radiation therapy (SRT), frequently followed by chemotherapy if the lesion was larger than 3 cm or radiotherapy and chemotherapy if the surgical margin or hilar or mediastinal nodes were positive at the time of operation. The five-year survival rates are very high, with 50-67% of these patients living at least five years after diagnosis if patients had a well-staged stage I NSCLC.

When surgery is not an option because the patient has heart problems or other complications, treatment alternatives include varying types of radiation therapy and chemotherapy, alone or in combination.

In this study, clinicians at the University of Texas M.D. Anderson Cancer Center (Houston, TX, USA) were looking to determine if traditional radiation therapy worked as well as the newer three-dimensional conformal radiation therapy (3D-CRT) at curing patients with early stage non-small cell lung cancer. 3D-CRT was developed to improve upon older types of radiation therapy by allowing clinicians to aim several radiation beams at the tumor to shape or "conform” the radiation to the lung. The strategy of the technology is to customize each beam, allowing doctors to deliver more radiation to the tumor while keeping it away from nearby healthy tissues.

Between 1978 and 2003, 200 patients with medically inoperable stage I NSCLC were treated with radiation therapy alone. Eighty-five received 3D-CRT while 115 received conventional therapy. Thirty-six percent of patients who received 3D-CRT lived five years after diagnosis compared to 10% who received the traditional therapy. Their causes of deaths were more related to intercurrent disease rather than cancer. Local failure was considerably reduced by 3D-CRT compared to conventional radiation therapy.

The findings were published in the September 1, 2006, issue of the International Journal of Radiation Oncology * Biology * Physics.



Related Links:
M.D. Anderson Cancer Center

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Medical Monitor
SILENIO D
Imaging Table
Stille imagiQ2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.